Cost-effectiveness of clinical breast examination screening programme among HER2-positive breast cancer patients: a modelling study.

Tran Thu NganSiobhán BrowneMartha GoodwinHoang Van MinhMichael DonnellyCiaran O'Neill

Published in: Breast cancer (Tokyo, Japan) (2022)

For HER2-positive patients and compared with no-screening, CBE screening programme in Vietnam is cost-effective from all investigated perspectives. CBE is a 'good value' intervention and should be considered for implementation throughout Vietnam as well as in LMICs where mammography is not feasible.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
positive breast cancer
randomized controlled trial
peritoneal dialysis
healthcare
prognostic factors
primary care
study protocol
magnetic resonance
clinical trial
magnetic resonance imaging
atomic force microscopy
patient reported